Analysis
| Earnings estimate |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|
| Number of analysts | 15 | 34 | 32 |
| Average estimate | 15.31 | 50.86 | 69.15 |
| Low estimate | 11.61 | 39.08 | 54.03 |
| High estimate | 18.76 | 71.60 | 96.18 |
| Last year EPS | 21.39 | 65.41 | 50.86 |
| Revenue estimate |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|
| Number of Analysts | 17 | 49 | 50 |
| Avg. estimate | 289.06B | 1.04T | 1.15T |
| Low estimate | 250.35B | 1.00T | 1.06T |
| High estimate | 300.72B | 1.10T | 1.23T |
| Last year sales | 280.15B | 996.35B | 1.04T |
| Sales growth | 0.03 | 0.04 | 0.10 |
| EPS trend |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|
| Current estimate | 15.31 | 50.86 | 69.15 |
| 7 days ago | 15.31 | 50.82 | 69.21 |
| 30 days ago | 16.30 | 52.26 | 70.57 |
| 60 days ago | 17.21 | 55.91 | 72.50 |
| 90 days ago | 19.42 | 62.47 | 75.19 |
| EPS revisions |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|
| Up last 7 days | 0 | 0 | 0 |
| Up last 30 days | 2 | 1 | 4 |
| Down last 7 days | 0 | 0 | 0 |
| Down last 30 days | 9 | 18 | 15 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | -0.616% |
| Next qtr. (Feb 2026) | -0.284% |
| Current year (2025) | -0.222% |
| Next 5 years (per annum) | -1.186% |
| Past 5 years (per annum) | -1.418% |
Recommendation
Buy